From Name

From Email

To Name

To Email

Message

New generation of drugs show early efficacy against drug-resistant TB

from Harvard Medical School via EurekAlert

New generation of drugs show early efficacy against drug-resistant TB Harvard Medical School via EurekAlert New treatment regimens for multidrug-resistant tuberculosis (MDR-TB) have shown early effectiveness in 85% of patients in a cohort that included many people with serious comorbidities that would have excluded them from clinical trials, according to the results of a new international study. The results, based on observational data from a diverse cohort of patients in 17 countries, underscore the need for expanded access to the recently developed TB medicines bedaquiline and delamanid. By contrast, the historical standard of care, still in use in much of the world, has approximately 60% treatment efficacy globally. READ MORE

more